Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer’s disease

Xinwen Zhang(University School), Rihua Wang(University School), Di Hu(University School), Xiaoyan Sun(University School), Hisashi Fujioka(University School), Kathleen C. Lundberg(Case Western Reserve University), E. Ricky Chan(Case Western Reserve University), QuanQiu Wang(Case Western Reserve University), Rong Xu(Case Western Reserve University), Margaret E. Flanagan(Northwestern University), Andrew A. Pieper(Louis Stokes Cleveland VA Medical Center), Xin Qi(University School)
Science Advances
December 4, 2020
Cited by 191Open Access
Full Text

Abstract

Myelin degeneration and white matter loss resulting from oligodendrocyte (OL) death are early events in Alzheimer's disease (AD) that lead to cognitive deficits; however, the underlying mechanism remains unknown. Here, we find that mature OLs in both AD patients and an AD mouse model undergo NLR family pyrin domain containing 3 (NLRP3)-dependent Gasdermin D-associated inflammatory injury, concomitant with demyelination and axonal degeneration. The mature OL-specific knockdown of dynamin-related protein 1 (Drp1; a mitochondrial fission guanosine triphosphatase) abolishes NLRP3 inflammasome activation, corrects myelin loss, and improves cognitive ability in AD mice. Drp1 hyperactivation in mature OLs induces a glycolytic defect in AD models by inhibiting hexokinase 1 (HK1; a mitochondrial enzyme that initiates glycolysis), which triggers NLRP3-associated inflammation. These findings suggest that OL glycolytic deficiency plays a causal role in AD development. The Drp1-HK1-NLRP3 signaling axis may be a key mechanism and therapeutic target for white matter degeneration in AD.


Related Papers